C17H20N4S, M=312.44 g/mol
Trade Mark: Zyprexa®
Treatment of schizophrenia and bipolar mania. Initial dose 10 mg, thereafter 20 mg. The maximum level is reached after 5-8 hours, half-life 21 up to 54 hours.
Do not use with older dementia patients as well as cases of glaucoma.
Substantial weight gain with increased diabetic risk, since Olanzapine intervenes in the insulin metabolism.
Therapeutic levels: 0.02 up to 0.03 µg/ml (serum/plasma).